[English]  [Pусский]  [中文]  
 
ctt-journal > Preliminary Program

Preliminary Program

pdf

4th Raisa Gorbacheva Memorial Meeting on Hematopoietic Stem Cell Transplantation, Saint Petersburg, Russia, September 18–20, 2010

Please click to enlarge.
Please click to enlarge.
Please click to enlarge.
September 18
Satellite Meetings

Venue: Conference hall of Baltic Star Hotel State Complex Palace of Congress (Konstantinovsky Palace), Strelna, Berezovaya Alley, 3, Saint Petersburg

Welcome reception

Konstantinovsky Palace, Strelna

September 19

8.00-8.30
Registration of participants

8.30-9.00
Opening speeches
Mikhail Didur
Boris Afanasyev
Thomas Buchner

Special Lectures
Chairmen: V. Savchenko, H.-J. Kolb, T. Buchner

9.00-9.30
Buchner Thomas. Raisa Gorbacheva Memorial Lecture. Strategies against relapse in AML

9.30-10.00
Kolb Hans-Jochem. Mechanisms of graft-versus-leukemia reactions in HLA-identical, HLA-haploidentical transplants and cord blood transplants

10.00-10.30
Ferrara James. Biomarkers of Acute GVHD

10.30-11.00
Fibbe Willem. Mesenchymal stromal cells: Safety issues for clinical application

11.00-11.30
Schmitz Norbert. G-CSF for the purposes of high-dose chemotherapy and hematopoietic stem cell transplantation

11.30-12.00
Burdach Stefan. Frontiers of cellular therapy in childhood cancer: overcoming tumor escape by selective alloreactive T cells

12.00-12.15
Zurabov Alexander. Investment in innovation activities in terms of cell technologies: view of venture investor

12.15-12.40
Coffee break and posters

Session 1. Hematopoietic Stem Cell Transplantation: GvHD-GvL
Chairmen: A. Zander, H. Greinix, W. Fibbe

12.40-13.00
Schmid Christoph. Innovative strategies to augment the Graft-versus-leukemia effect in allogeneic stem cell transplantation for AML

13.00-13.20
Ayuk Francis. Diagnosis and therapy of chronic GvHD

13.20-13.40
Holler Ernst. GvHD - actual pathophysiological and therapeutical aspects

13.40-13.55
Afanasyev Boris. Treatment of patients with post-transplant relapses

13.55-14.10
Savchenko Valeriy. Evidence-based aspects of mesenchymal stem cells using for GVHD prophylaxis and treatment

14.10-15.00
Lunch. Poster session

Session 2. Hematopoietic Stem Cell Transplantation: GvHD-GvL, Extracorporeal photopheresis
Chairmen: V. Koza, J. Ferrara, F. Auyk

15.00-15.20
Greinix Hildegard. Extracorporeal photopheresis for treatment of graft-versus-host disease

15.20-15.40
Heshmati Farhad. Extracorporeal photochemotherapy, indications, techniques and mechanisms of action

15.40-16.00
Del Fante Claudia. Extracorporeal photopheresis in the treatment of GvHD in children

Session 3. Hematopoietic Stem Cell Transplantation. Pediatric Session
Chairmen: O. Aleinikova, S. Kojima, S. Burdach

16.00-16.20
Muller Ingo. Clinical potential of mesenchymal stem cells in pediatric BMT

16.20-16.35
Aleinikova Olga. Bone marrow transplantation for children with acute myeloid leukemia: pro et contra

16.35-16.55
Wagemaker Gerard. Genetic correction of hematopoietic stem cells for advanced cell therapy of lysosomal enzyme deficiencies

16.55-17.10
Rumyantsev Alexander. Circulating nucleic acids in biological fluids and their role in detection of minimal residual disease in children with hematological malignancies

17.10-17.20
Semenova Elena. Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning regimen in children

17.20-17.30
Maschan Alexey. Kinetics of progenitor cell mobilization using G-CSF and plerixafor in children with hematological and nonhematological malignancies

17.30-17.40
Samochatova Elena. Current treatment of mature B-NHL/ALL in children and adolescent in regional pediatric clinics of Russian Federation

17.40-17.55
Mentkevich George. High dose chemotherapy with PBSC support in pediatric brain tumor patients

September 20
Session 4. Hematopoietic Stem Cell Transplantation in Patients with Haematological Malignancies
Chairmen: A. Sureda, T. Ruutu, Poddubnaya I.

9.00-9.20
Sureda Anna. Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma

9.20-9.40
Zander Axel. Hematopoietic stem cell transplantation in patients with myelofibrosis

9.40-10.00
Ruutu Tapani. A second allogeneic hematopoietic stem cell transplantation for relapse of malignant disease: Outcome and Predictive Factors

10.00-10.20
Wisloff Finn. The title will be detailed

10.20-10.40
Tangen Jon Magnus. The effectiveness of second high dose melphalan with autologous stem cell support in relapsed myeloma patients

10.40-10.50
Konstantinova Tatiana. Hematopoietic stem cell transplantation (HSCT) in the treatment of Hodgkin’s lymphoma (HL) patients: Experience in the Sverdlovsk region

Session 5. Hematopoietic Stem Cell Transplantation: Aplastic Anemia
Chairmen: J. Marsh, I. Muller, A. Rumyantsev

10.50-11.10
Kojima Seiji. Treatment of acquired aplastic anemia in children

11.10-11.30
Marsh Judith. Current aplastic anaemia guidelines and unresolved problems

11.30-11.40
Novichkova Galina. Treatment results of children with acquired aplastic anemia after failed first course of combining immunosuppressive therapy

11.40-11.50
Kulagin Alexander. Bone marrow transplantation and immunosuppressive therapy for acquired aplastic anemia: A 15-year two-center experience

11.50-12.10
Coffee break and posters

Session 6. Hematopoietic Stem Cell Transplantation: Infection complications
Chairmen: H. Lellek, A. Maschan, G. Maschmeyer

12.10-12.30
Maschmeyer Georg. Pre-emptive approach to invasive fungal infections therapy

12.30-12.50
Lellek Heinrich. Treatment of fungal diseases post BMT

12.50-13.10
Bialek Ralf. PCR-Diagnostic of fungal infections

13.10-13.25
Klimko Nicolay. International guidelines on IFI management (ECIL 3)

13.25-13.40
Klyasova Galina. Optimizing antimicrobial therapy: From the bench to the bedside

13.40-13.50
Vavilov Vladimir. Epidemiology and structure of septic complications in HSCT recipients

13.50-15.00
Lunch. Poster session

Session 7. Basic researches
Chairmen: G. Wagemaker, B. Fehse, M. Borset

15.00-15.20
Sanderson Ralph. Heparanase promotes the aggressive phenotype of myeloma tumors and is a novel target for myeloma therapy

15.20-15.40
Koza Vladimir. WMDP accreditation – mission (im)possible

15.40-16.00
Borset Magne. Multiple Myeloma - Interactions between tumor and microenvironment

16.00-16.20
Fehse Boris. LeGO vectors for colourful cell marking in cell biology studies

16.20-16.40
Poster Awards
Chairmen: V. Savchenko, F. Wisloff, A. Zander, G. Mentkevich

16.40-17.00
Closing Remarks

last updated 30 August 2010

top